TEVA GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Teva- Pharmaceutical Industries Ltd
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.
Current Price
$35.73
-0.78%GoodMoat Value
$21.98
38.5% overvaluedProfile
Valuation (TTM)
Market Cap$41.08B
P/E26.27
EV—
P/B5.19
Shares Out1.15B
P/Sales2.37
Revenue$17.35B
EV/EBITDA16.43
Teva- Pharmaceutical Industries Ltd (TEVA) Quality Analysis
TEVA Profitability
Profitability trend analysis coming soon
TEVA Growth
Growth trend analysis coming soon
TEVA Financial Health
Financial health indicators coming soon
TEVA Quality & Fundamental Analysis
Teva- Pharmaceutical Industries Ltd (TEVA) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE. This quality analysis page evaluates Teva- Pharmaceutical Industries Ltd's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Teva- Pharmaceutical Industries Ltd has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 9.01% and a return on equity (ROE) of 19.77%. Return on assets (ROA) stands at 3.84%.
The debt-to-equity ratio is 2.16, with a current ratio of 1.04. Operating margin is 12.61%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Teva- Pharmaceutical Industries Ltd is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.